公开(公告)号：CA2919223A1

公开(公告)日：2015-02-26

申请号：CA2919223

申请日：2014-08-08

Applicant: BAXTER INT ,  BAXTER HEALTHCARE SA

Inventor： AKONUR ALP ,  LEYPOLDT JOHN KENNETH ,  LO YIN-CHENG ,  AGAR BARIS UGAR

IPC: G06F19/00

Abstract: A method of predicting serum potassium concentrations in a patient during hemodialysis includes measuring serum potassium concentrations of the patient over a hemodialysis treatment session time and an ultrafiltration rate calculated by a difference between pre- and post-dialytic body weight of the patient during an initial hemodialysis treatment session divided by a total treatment time of the treatment session and estimating a potassium mobilization clearance and a pre-dialysis distribution volume of potassium for the patient. Serum potassium concentrations of the patient can then be predicted at any time during any hemodialysis treatment session with the estimated potassium mobilization clearance and pre-dialysis distribution volume of potassium of the patient.

公开(公告)号：MX2016002083A

公开(公告)日：2016-06-23

申请号：MX2016002083

申请日：2014-08-08

Applicant: BAXTER INT

Inventor： LEYPOLDT JOHN KENNETH ,  AKONUR ALP ,  LO YIN-CHENG ,  AGAR BARIS UGAR

IPC: G06F19/00

Abstract: Un método para predecir concentraciones de potasio en suero en un paciente durante la hemodiálisis incluye medir las concentraciones de potasio en suero del paciente durante un tiempo de la sesión de tratamiento de hemodiálisis y una tasa de ultrafiltración calculada mediante una diferencia entre el peso corporal post- y pre-dialítico del paciente durante una sesión de tratamiento de hemodiálisis dividida entre un tiempo total de tratamiento de la sesión de tratamiento y estimar una depuración de movilización del potasio y un volumen de distribución pre-diálisis del potasio para el paciente. Las concentraciones de potasio en suero del paciente pueden entonces predecirse en cualquier momento durante cualquier sesión de tratamiento de hemodiálisis con la depuración de movilización del potasio estimada y el volumen de distribución pre-diálisis del paciente.

公开(公告)号：AU2014309285A1

公开(公告)日：2016-01-28

申请号：AU2014309285

申请日：2014-08-08

Applicant: BAXTER HEALTHCARE SA ,  BAXTER INT

Inventor： AKONUR ALP ,  LEYPOLDT JOHN KENNETH ,  LO YIN-CHENG ,  AGAR BARIS UGAR

IPC: G06F19/00

Abstract: A method of predicting serum potassium concentrations in a patient during hemodialysis includes measuring serum potassium concentrations of the patient over a hemodialysis treatment session time and an ultrafiltration rate calculated by a difference between pre- and post-dialytic body weight of the patient during an initial hemodialysis treatment session divided by a total treatment time of the treatment session and estimating a potassium mobilization clearance and a pre-dialysis distribution volume of potassium for the patient. Serum potassium concentrations of the patient can then be predicted at any time during any hemodialysis treatment session with the estimated potassium mobilization clearance and pre-dialysis distribution volume of potassium of the patient.

公开(公告)号：SG67282A1

公开(公告)日：1999-09-21

申请号：SG1995002030

申请日：1993-05-12

Applicant: BAXTER INT

Inventor： LO YIN-CHENG ,  PATEL INDRAJIT T ,  WOO LECON ,  CHEUNG Y WILSON ,  LING MICHAEL T K

IPC: A61M5/14 ,  A61J1/10 ,  A61L29/00 ,  A61L29/08 ,  A61L31/00 ,  A61M1/00 ,  A61M1/28 ,  A61M25/00 ,  B32B27/08

Abstract: The present invention provides an improved coextruded medical port tubing. The medical port tubing provides characteristics that are desirable in the medical industry and therefore can be used as a medical port tubing in, for example, renal therapy or blood donor tubes. To this end, the present invention provides a coextruded medical grade port tubing comprising: an outer layer comprising a blend of polypropylene copolymer and styrene-ethylene-butylene-styrene copolymer; a tie layer; and a core layer comprising polyvinyl chloride.